Evaluation of the effect of Osvix on tinnitus and Headache in patient with transverse venous sinus stenosis or hypoplasia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220715055474N1

Enrollment

Registered

2023-08-12

Start date

2023-05-15

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus and headache and transverse venous sinus stenosis.

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Tinnitus and headache with venous sinus stenosis or hypoplasia

Exclusion criteria

Exclusion criteria: Known neurological disease Pregnancy or breastfeeding Patient dissatisfaction

Design outcomes

Primary

Measure	Time frame
Severity of disability caused by tinnitus and headache by Tinnitus handicap inventory and Headache disability index. Timepoint: At the beginning of the study and thirty days after the intervention. Method of measurement: Tinnitus handicap inventory and Headache disability index.	—

Secondary

Measure	Time frame
Tinnitus and headache severity score measured by Tinnitus handicap inventory and Headache disability index questionnaires. Timepoint: 30 days after the intervention. Method of measurement: Tinnitus and headache severity score measured by Tinnitus handicap inventory and Headache disability index questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Mirzaei

Artesh University of Medical Sciences

Amteh76@yahoo.com+98 21 8609 6350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026